ALK and neoplasm: New tumors include novel eosinophilic solid and cystic RCC, ALK rearrangement-associated RCC, and RCC with fibromyomatous stroma (Figure 6), emerging (eosinophilic vacuolated tumor and thyroid-like follicular RCC), and provisional (low-grade oncocytic tumor, atrophic kidney-like lesion, and biphasic hyalinizing psammomatous RCC) tumor entities.